-+ 0.00%
-+ 0.00%
-+ 0.00%

BOEHRINGER INGELHEIM : SURVODUTIDE DOES NOT INCREASE RISK OF CARDIOVASCULAR DEATH, NON-FATAL STROKE OR MI VERSUS PLACEBO

Reuters·11/09/2026 14:45:06

Please log in to view news